Your browser doesn't support javascript.
loading
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
Tapper, Elliot B; Goldberg, David; Parikh, Neehar D; Terrault, Norah A; Welch, Nicole; Sharpton, Suzanne; Hameed, Bilal; Khalili, Mandana; Stolz, Andrew; Verna, Elizabeth C; Brown, Robert S; Sanyal, Arun J; VanWagner, Lisa; Ladner, Daniela P; Moylan, Cynthia A; Diehl, Anna Mae; Jones, Patricia D; Loomba, Rohit; Dasarathy, Srinivasan; Simonetto, Douglas A; Shah, Vijay H; Bajaj, Jasmohan S.
Afiliação
  • Tapper EB; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Goldberg D; Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Parikh ND; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Terrault NA; Division of Gastrointestinal and Liver Diseases, Keck Medicine of University of Southern California, Los Angeles, California, USA.
  • Welch N; Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.
  • Sharpton S; NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California, USA.
  • Hameed B; Division of Gastroenterology and Hepatology, University of California-San Francisco, San Francisco, California, USA.
  • Khalili M; Division of Gastroenterology and Hepatology, University of California-San Francisco, San Francisco, California, USA.
  • Stolz A; Division of Gastrointestinal and Liver Diseases, Keck Medicine of University of Southern California, Los Angeles, California, USA.
  • Verna EC; Division of Digestive and Liver Diseases, Columbia University, New York, New York, USA.
  • Brown RS; Division of Gastroenterology & Hepatology, Weill Cornell Medicine New York, New York, USA.
  • Sanyal AJ; Division of Gastroenterology and Hepatology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
  • VanWagner L; Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Ladner DP; Division of Transplantation, Department of Surgery, Northwestern University, Chicago, Illinois, USA.
  • Moylan CA; Division of Gastroenterology and Hepatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Diehl AM; Division of Gastroenterology and Hepatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Jones PD; Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Loomba R; NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California, USA.
  • Dasarathy S; Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.
  • Simonetto DA; Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, Minnesota, USA .
  • Shah VH; Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, Minnesota, USA .
  • Bajaj JS; Division of Gastroenterology and Hepatology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
Am J Gastroenterol ; 2024 Jul 17.
Article em En | MEDLINE | ID: mdl-39018024
ABSTRACT

INTRODUCTION:

One of the primary goals of the Liver Cirrhosis Network (LCN) is to develop a cohort study to better understand and predict the risk of hepatic decompensation and other clinical and patient-reported outcomes among patients with Child A cirrhosis.

METHODS:

The LCN consists of a Scientific Data Coordinating Center and 10 clinical centers whose investigators populate multiple committees. The LCN Definitions and Measurements Committee developed preliminary definitions of cirrhosis and its complications by literature review, expert opinion, and reviewing definition documents developed by other organizations. The Cohort Committee developed the study protocol with the input of the steering committee.

RESULTS:

The LCN developed a prospective cohort study to describe and predict the rates of incident clinical events pertaining to first decompensation and patient-reported outcomes. The LCN developed a pragmatic definition of compensated cirrhosis incorporating clinical, laboratory, imaging, and histological criteria. Definitions of incident and recompensated ascites, overt hepatic encephalopathy, variceal hemorrhage, bleeding because of portal gastropathy, and hepatocellular carcinoma were also codified.

DISCUSSION:

The LCN Cohort Study design will inform the natural history of cirrhosis in contemporary patients with compensated cirrhosis. The LCN Definitions and Measures Committee developed criteria for the definition of cirrhosis to standardize entry into this multicenter cohort study and standardized criteria for liver-related outcome measures. This effort has produced definitions intended to be both sensitive and specific as well as easily operationalized by study staff such that outcomes critical to the LCN cohort are identified and reported in an accurate and generalizable fashion. REGISTRATION NCT05740358.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article